Denali Therapeutics Inc.

Free public records show Denali Therapeutics Inc. in 7 of the markets we cover. It is not a key player in our research.

[1] ClinicalTrials.gov, Studies led by Denali Therapeutics Inc. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.

Public data

Free public data on Denali Therapeutics Inc.

From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.

About our sources

Company facts

Stock listing
NASDAQ: DNLI
Type
Medicines

Source: SEC EDGAR, Company filings, CIK 1714899. Retrieved 13 Nov 2026.

Trials over time

Studies Denali Therapeutics Inc. leads, by the year they started and their phase

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4
  • No phase (devices, observational)

Source: ClinicalTrials.gov, Studies with Denali Therapeutics Inc. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.

Markets where public records show them

Markets we cover where free public records show Denali Therapeutics Inc.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.

Search all reports for Denali Therapeutics Inc. All companies